Evidence map›Paper›PMID 23735285›Full record

ArticleEmerging infectious diseases2013

Treatment of tularemia in pregnant woman, France.

Charlotte Dentan, Patricia Pavese, Isabelle Pelloux, Sandrine Boisset, Jean-Paul Brion, Jean-Paul Stahl, Max Maurin

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Emerging infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response - United States, 2025.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2025
    Guideline
  2. Article
  3. Review
  4. Article
  5. Identification ofBMJ case reports · 2024
    Article
  6. Review
  7. Review
  8. Serendipitous Treatment of Tularemia in Pregnancy.Open forum infectious diseases · 2019
    Article
  9. Frontiers in cellular and infection microbiology · 2017
    Review
  10. Article
  11. Article
  12. Bis-indolic compounds as potential new therapeutic alternatives for tularaemia.Frontiers in cellular and infection microbiology · 2014
    Article
  13. New therapeutic approaches for treatment of tularaemia: a review.Frontiers in cellular and infection microbiology · 2014
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Charlotte DentanCentre Hospitalier Universitaire de Grenoble, Grenoble, France.
Patricia Pavese
Isabelle Pelloux
Sandrine Boisset
Jean-Paul Brion
Jean-Paul Stahl
Max Maurin
Centre d'Immunologie et des Maladies Infectieuses · FRHospital for Tropical Diseases · VNUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A pregnant woman who had oropharyngeal tularemia underwent treatment with azithromycin and lymph node resection and recovered without obstetrical complication or infection in the child. Azithromycin represents a first-line treatment option for tularemia during pregnancy in regions where the infecting strains of Francisella tularensis have no natural resistance to macrolides.

Indexed as

AdultAnti-Bacterial AgentsAzithromycinFemaleFranceFrancisella tularensisHumansLymph NodesPregnancyTularemiaAnti-Bacterial AgentsAzithromycinantimicrobial resistanceazithromycinbacteriaFranceFrancisella tularensismacrolidespregnancytularemiazoonoses

Identifiers

PMID23735285
PMCPMC3713841
OpenAlexW1997422898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.